Filters: Author is de Ledinghen, Victor [Clear All Filters]
"Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation: Results from the CO23 ANRS CUPILT study.", Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016 Jun 27.
"Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.", Journal of hepatology, 2016 Jun 1.
"Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).", The Lancet. Infectious diseases, vol. 15, issue 4, pp. 397-404, 2015 Apr.
"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.", Journal of hepatology, vol. 59, issue 3, pp. 434-41, 2013 Sep.
"Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.", Hepatology (Baltimore, Md.), vol. 55, issue 1, pp. 58-67, 2012 Jan.